Current DVT Prophylaxis Guidelines with Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH) Are Inadequate for MICU Patients by Anti-Xa Levels

被引:0
|
作者
Velasquez, A. [1 ]
Patel, H. [1 ]
Shaz, D. [1 ]
Perez, R. L. [2 ]
Leeper, K. V. [1 ]
机构
[1] Emory Crawford Long Hosp, Atlanta, GA USA
[2] VAMC Atlanta, Decatur, GA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A6093
引用
收藏
页数:1
相关论文
共 50 条
  • [1] ANTI-XA ASSAYS FOR UNFRACTIONATED HEPARIN (UFH) AND LOW MOLECULAR WEIGHT HEPARIN (LMWH): ANALYSIS OF THE QUALITY OF PERFORMANCE BY NORTH AMERICAN LABORATORIES
    Black, Lesley
    Selby, Rita
    Hoffman, Suzanne
    Chen, Dong
    Meijer, Piet
    Plumhoff, Elizabeth
    Van Cott, Elizabeth
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E60 - E60
  • [2] Is monitoring anti-Xa levels necessary in pregnant women on therapeutic low molecular weight heparin (LMWH)?
    Temming, Lorene A.
    Young, Omar M.
    Stout, Molly J.
    Tuuli, Methodius G.
    Macones, George A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S157 - S158
  • [3] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [4] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
  • [5] Anti-Xa monitoring is required in pregnant women on low molecular weight heparin (LMWH)
    Simpson, V. M. A.
    Pescott, M.
    Peebles, D.
    Cohen, H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1060 - 1060
  • [6] Low-molecular weight heparin (LMWH) in pregnancy: Role of anti-Xa monitoring
    Abu-Hajir, M
    Kuhlmann, RS
    Wigton, TR
    Friedman, KD
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 846 - 846
  • [7] LOW MOLECULAR WEIGHT HEPARIN (LMWH) COMPARED WITH UNFRACTIONATED HEPARIN (UFH) FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN HOSPITALIZED PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Ruiz, Jose R.
    Monteiro, Joao Filipe G.
    Argueta, Erick A.
    Fine, Sean
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1128 - S1128
  • [8] A PROSPECTIVE RANDOMIZED TRIAL OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) VERSUS UNFRACTIONATED HEPARIN (UFH) IN PATIENTS WITH GYNECOLOGIC CANCER
    HEILMANN, L
    SCHNEIDER, D
    HERRIE, B
    VONTEMPELHOFF, F
    MANSTEIN, J
    WOLF, H
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 974 - 974
  • [9] THROMBOSIS PROPHYLAXIS IN GYNECOLOGY - A RANDOMIZED DOUBLE-BLIND-STUDY BETWEEN LOW-MOLECULAR WEIGHT HEPARIN (LMWH) AND UNFRACTIONATED HEPARIN (UFH)
    HEILMANN, L
    KRUCK, M
    SCHINDLER, AE
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1989, 49 (09) : 803 - 807
  • [10] Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin
    Kovacs, MJ
    Keeney, M
    MacKinnon, K
    Boyle, E
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1999, 21 (01): : 55 - 60